Enterprise system will facilitate most complex toxicology study designs in South Korea
Cedar Knolls, NJ and Daejeon, South Korea (PRWEB) August 13, 2009 -- Xybion Medical Systems, a world leader in preclinical data management solutions and the developer of Pristima™ the premier preclinical solution on the market, is pleased to announce that Korea Institute of Toxicology (KIT) is upgrading to Pristima at its facilities in Daejeon and Jeongeup, South Korea.
Since 2002, KIT has been a Xybion client and has used Xybion's previous PATH/TOX SYSTEM suite as an integral business driver; using the system to plan, collect, manage and report all of its General Toxicology data. With this upgrade, KIT has expanded its software licenses to include the Pharmacy and Reproductive Toxicology modules so as to implement the full Pristima suite to cover all of its toxicology studies. With this system upgrade and expansion, KIT also chose to license Xybion's standard validation package to expedite the project and provide for a solid validation project.
Dr. Pradip Banerjee, Xybion's CEO, stated that "this upgrade and expansion of deployed modules at KIT further exemplifies the advantages of a completely integrated system that has more built-in functionality and business intelligence than any other product on the market."
The Daejeon and Jeongeup sites together comprise of over 500,000 square feet of facility space so KIT is the largest, most well-known GLP facility in South Korea and serves markets all over the world. With a vast experience in all study types, combined with highly automated procedures and reporting capabilities, KIT can define, perform and report client studies in record time and with the highest of quality. PATH/TOX SYSTEM and now Pristima, serve to capture and integrate all of the preclinical data at KIT while serving to enforce SOP's
Copyright©2009 Vocus, Inc.
All rights reserved